Petr Vladimirovich Kruglyakov
Algemeen Directeur bij PHARMSYNTHEZ
Profiel
Petr Vladimirovich Kruglyakov is currently the Director General at Pharmsynthez PJSC.
He previously worked as the Director-Research & Development at Artgen Biotech PJSC from 2010 to 2011 and as the Executive Director at SynBio LLC from 2013 to 2014.
Dr. Kruglyakov obtained his undergraduate degree from the State University of St. Petersburg.
Actieve functies van Petr Vladimirovich Kruglyakov
| Bedrijven | Functie | Begin |
|---|---|---|
| PHARMSYNTHEZ | Algemeen Directeur | 01-01-2014 |
Eerdere bekende functies van Petr Vladimirovich Kruglyakov
| Bedrijven | Functie | Einde |
|---|---|---|
SynBio LLC
 SynBio LLC Pharmaceuticals: MajorHealth Technology SynBio LLC engages in original research and introduction of conceptually new medicines. The firm’s medicines help treat diseases like liver disease, cardiovascular disease, acute leukemia, growth hormone deficiency and diabetes milletus. Its work is based on scientific developments and conducted in cutting edge laboratories. The company was founded in 2011 and is headquartered in Moscow, Russian Federation. | Algemeen Directeur | 01-01-2013 |
| HUMAN STEM CELLS INSTITUTE | Hoofd Techniek/Wetenschap/O&O | 01-01-2011 |
Opleiding van Petr Vladimirovich Kruglyakov
| State University of St. Petersburg | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| HUMAN STEM CELLS INSTITUTE | Health Services |
| PHARMSYNTHEZ | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
SynBio LLC
SynBio LLC Pharmaceuticals: MajorHealth Technology SynBio LLC engages in original research and introduction of conceptually new medicines. The firm’s medicines help treat diseases like liver disease, cardiovascular disease, acute leukemia, growth hormone deficiency and diabetes milletus. Its work is based on scientific developments and conducted in cutting edge laboratories. The company was founded in 2011 and is headquartered in Moscow, Russian Federation. | Health Technology |
